Nebivolol Eg

Nebivolol, the active ingredient in Nebivolol Eg, is a beta blocker presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients. GNH USA supplies Nebivolol Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension. - Heart failure (reduced ejection fraction): improves ventricular function and reduces hospitalization risk. - Left ventricular systolic dysfunction: supports cardiac output and symptom control in chronic heart failure.

Nebivolol may cause adverse reactions that vary in frequency and severity. Common Side Effects: - Headache: mild to moderate pain in the head region. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: reduced energy or feeling unusually tired. - Bradycardia: slower than normal heart rate. - Nausea: upset stomach with urge to vomit. - Peripheral edema: swelling of ankles or lower legs. Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Atrioventricular block: impaired electrical conduction in the heart. - Bronchospasm: narrowing of airways, particularly in asthmatic patients. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Hepatic enzyme elevation: abnormal liver function tests. - Hypotension: dangerously low blood pressure causing faintness.

Nebivolol should be used with careful clinical monitoring. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Cardiac function assessment: evaluate heart rate and ECG, especially in patients with conduction disorders. - Asthma or COPD caution: use only if benefits outweigh risk of bronchospasm. - Concomitant beta‑blocker use: avoid duplicate therapy to prevent excessive β‑blockade. - Renal impairment adjustment: consider dose modification in severe renal dysfunction. - Store at room temperature: keep in the original container, protect from moisture and light.

Nebivolol can interact with several drug classes, requiring clinical awareness. Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): may cause severe bradycardia or AV block. - Anti‑arrhythmic agents (e.g., amiodarone): increase risk of conduction abnormalities. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced hypotensive effect. - Diuretics: potential for excessive blood pressure drop. - NSAIDs: may blunt antihypertensive response. - Antidepressants (e.g., SSRIs): possible pharmacokinetic changes.